Cargando…

Hepatobiliary Manifistations of COVID-19 in Sickle Cell Disease: A Case Report

Hepatobiliary manifestation of COVID-19 in Sickle Cell Disease: A Case report. Background and aim: SARS-CoV-2 belongs to the Coronaviridae family, and the virus began spreading worldwide in late December 2019. It mainly affects the respiratory system. However, some studies have shown an increasing n...

Descripción completa

Detalles Bibliográficos
Autores principales:	Alghamdi, Badria M., Kashari, Ohoud F.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society of Hematology 2020
Materias:	113.Hemoglobinopathies, Excluding Thalassemia-New Genetic Approaches to Sickle Cell Disease
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8330333/ http://dx.doi.org/10.1182/blood-2020-142657

Ejemplares similares

Presentation, Management and Outcomes of COVID-19 Patients with Sickle Cell Disease
por: Anusim, Nwabundo, et al.
Publicado: (2020)

Drepadom - Home Care Services and Hospitalizations for Sickle Cell Disease Patients during the Covid-19 Pandemic
por: De Luna, Gonzalo, et al.
Publicado: (2020)

Whole Blood Adhesion to VCAM-1 and P-Selectin and RBC Mechanical Fragility Can be Compromised in Long COVID-19 Patients with Sickle Cell Disease
por: Tarasev, Michael, et al.
Publicado: (2021)

Outcomes of Sickle Cell Disorders in COVID-19 Infection: An Institutional Experience
por: Sewaralthahab, Sarah, et al.
Publicado: (2020)

Hospitalization and Case Fatality in Individuals with Sickle Cell Disease and COVID-19 Infection
por: Mucalo, Lana, et al.
Publicado: (2020)

Healthcare Utilization Among Children and Adolescents with Sickle Cell Disease during the COVID-19 Pandemic
por: Nowlin, Andrea, et al.
Publicado: (2020)

Actions of L-Glutamine vs. COVID-19 Suggest Additional Benefit in Sickle Cell Disease
por: Abdelaal, Mahmoud A.Z., et al.
Publicado: (2020)

Sickle Cell Disease Related Outcomes in Patients Evaluated for COVID-19 Infections in South Carolina
por: Noisette, Laurence, et al.
Publicado: (2020)

Venous Thromboembolism Prophylaxis Practices for Patients with Sickle Cell Disease Pre and during the COVID-19 Pandemic
por: Davila, Jennifer G., et al.
Publicado: (2020)

Impact of Sickle Cell Trait on Morbidity and Mortality from Sars-Cov-2 Infection
por: Merz, Lauren E., et al.
Publicado: (2020)

Identification of the Pitfalls in the Attempted Use of Extracorporeal Membrane Oxygenation in an Adult Patient with Sickle Cell Disease and Severe Acute Chest Syndrome
por: Tanenbaum, Mira T, et al.
Publicado: (2019)

COVID-19 in Hospitalized Patients with Sickle Cell Disease
por: Guarino, Stephanie, et al.
Publicado: (2021)

COVID-19 Infection and Outcomes at a Comprehensive Sickle Cell Center
por: El Rassi, Fuad, et al.
Publicado: (2021)

Sickle Cell Disease and COVID-19 Infection: A Single-Center Experience
por: Devarashetty, Sindhu, et al.
Publicado: (2021)

Impact of the COVID-19 Pandemic on Acute Care Visits for Patients with Sickle Cell Disease
por: Orkoulas-Razis, Dennis, et al.
Publicado: (2021)

Excess All-Cause Mortality in 2020 for People Living with Sickle Cell Disease in New York City
por: Curtis, Susanna A, et al.
Publicado: (2021)

Thrombosis and Risk Management in Paediatric Inflammatory Multisystem Syndrome - Temporally Associated with Sars-CoV2 (PIMS-TS)
por: Lam, Ho Pui Jeff, et al.
Publicado: (2020)

Incidence of Sars-COV-2 Infection in Sickle Cell Patients Presenting with a Painful Crisis, a 12 Month Prospective Cohort Study
por: Konté, Kadère, et al.
Publicado: (2021)

Sickle Cell Disease (SCD) As a Risk for COVI19 Compared to Those without SCD Among Patients Admitted in a Large Urban Center, As Estimated By PCR Sars-v-2 Positive Vs Negative Testing
por: Adamkiewicz, Tom, et al.
Publicado: (2021)

Impact of Crizanlizumab on Acute Medical Care Utilization in the Height of the COVID-19 Pandemic
por: Rao, Shivani, et al.
Publicado: (2021)

Retrospective Study Evaluating Effect of Voxelotor Treatment on Acute Care Utilization during the Peak of COVID-19
por: Rao, Shivani, et al.
Publicado: (2021)

Sickle Cell Disease in Africa: A Neglected Cause of Early Childhood Mortality
por: Grosse, Scott D., et al.
Publicado: (2011)

Results of Operative and Nonoperative Treatment of Rockwood Types III and V Acromioclavicular Joint Dislocation: A Prospective, Randomized Trial With an 18- to 20-Year Follow-up
por: Joukainen, Antti, et al.
Publicado: (2014)

History of Pain is Associated with Hospitalization and Severe Course of COVID-19 in Children with Sickle Cell Disease
por: Mucalo, Lana, et al.
Publicado: (2021)

Genetic modifiers of fetal hemoglobin affect the course of sickle cell disease in patients treated with hydroxyurea
por: Allard, Pierre, et al.
Publicado: (2021)

The State of Sickle Cell Disease Care in the United States: How Can Emergency Medicine Contribute?
por: Giroir, Brett P., et al.
Publicado: (2020)

Emergency Department Utilization for Patients Living With Sickle Cell Disease: Psychosocial Predictors of Health Care Behaviors
por: Abdallah, Khadijah, et al.
Publicado: (2020)

Is sickle cell disease a risk factor for severe COVID‐19 outcomes in hospitalized patients? A multicenter national retrospective cohort study
por: Abdulrahman, Abdulkarim, et al.
Publicado: (2021)

Sickle cell disease patients with COVID‐19 in Guadeloupe: Surprisingly favorable outcomes
por: Bernit, Emmanuelle, et al.
Publicado: (2022)

Patterns of healthcare utilization among patients with sickle cell disease hospitalized with pain crises
por: Rodday, Angie Mae, et al.
Publicado: (2020)

Acute kidney injury in Jamaicans with sickle cell disease hospitalized with COVID‐19 infection
por: Fisher, Lori‐Ann, et al.
Publicado: (2023)

Sickle cell anemia and pregnancy: Profile of hemodynamic changes in sickle cell pregnant women in Kinshasa
por: Mikobi, Tite Minga, et al.
Publicado: (2023)

Alpha‐globin gene triplication and its effect in beta‐thalassemia carrier, sickle cell trait, and healthy individual
por: Hamid, Mohammad, et al.
Publicado: (2021)

UK media reporting of NICE recommendation of crizanlizumab for patients with sickle cell disease
por: Buka, Richard J, et al.
Publicado: (2022)

Clusters of pain trajectories among patients with sickle cell disease hospitalized for vaso‐occlusive crisis: A data‐driven approach
por: Rodday, Angie Mae, et al.
Publicado: (2020)

Gabapentin for acute pain in sickle cell disease: A randomized double‐blinded placebo‐controlled phase II clinical trial
por: Puri, Latika, et al.
Publicado: (2021)

Impact of COVID‐19 on incidence, clinical presentation, and prognosis of acute chest syndrome in patients with sickle cell disease
por: Dubois, Gabin, et al.
Publicado: (2023)

A pilot clinical phase II trial MemSID: Acute and durable changes of red blood cells of sickle cell disease patients on memantine treatment
por: Mahkro, Asya, et al.
Publicado: (2020)

Family planning needs of young adults with sickle cell disease
por: Linton, Elizabeth A., et al.
Publicado: (2023)

Hydroxyurea treatment for adult sickle cell anemia patients in Kinshasa
por: Kabuyi, Paul Lumbala, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_s724ca7umefjggcbohbgv1beuk